Author:
Maspero Jorge F.,Cruz Alvaro A.,Beltran Cesar Fireth Pozo,Ali Munive Abraham,Montero-Arias Felicia,Hernandez Pliego Ramses,Farouk Hisham
Funder
AstraZeneca
Novartis
National Institutes of Health
Subject
Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine
Reference80 articles.
1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet Respir Med,2017
2. Global Initiative for Asthma strategy 2021: executive summary and rationale for key changes;Reddel;Am J Respir Crit Care Med,2022
3. Economic burden of illness among patients with severe asthma in a managed care setting;Chastek;J Manag Care Spec Pharm,2016
4. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014
5. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States;Hankin;J Allergy Clin Immunol,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献